MyChart vs. Forus (formerly Tandem)
A side-by-side comparison based on G2 review data.
| Metric | MyChart | Forus (formerly Tandem) |
|---|---|---|
| Overall rating | 4.4 | 5.0 |
| Review count | 40 | 31 |
| Ease of use | 9.1 | 9.9 |
| Ease of setup | 8.2 | 10.0 |
| Quality of support | 9.0 | 9.9 |
| Meets requirements | 9.2 | 9.6 |
| NPS | 57.894737 | 100 |
| Small Business | 37.5% | 83.3% |
| Mid-Market | 12.5% | 13.3% |
| Enterprise | 50.0% | 3.3% |
| Total page views | 729 | 302 |
| Total LLM citations | 1,945 | 201 |
MyChart
MyChart Bedside provides access to their latest lab results, a way to message their nurses and doctors, and clear, nontechnical explanations of their treatment.
Forus (formerly Tandem)
Forus (formerly Tandem) accelerates medicine for the people who need it, prescribe it, and create it. We are building the AI-powered network that connects doctors, pharmacies, payers, and biopharma to bring new science to patients.